Long-term follow-up of intraocular pressure and pressure-lowering medication in patients after ab-interno trabeculectomy with the Trabectome
Sign Up to like & getrecommendations! Published in 2019 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-019-04259-5
Abstract: BackgroundThe minimally invasive ab-interno trabeculectomy (AIT) via electro-ablation with the Trabectome has been on the European market since 2009. Many studies have proven the safety and efficacy of the procedure. Up until now, studies investigating… read more here.
Keywords: intraocular pressure; long term; interno trabeculectomy; lowering medication ... See more keywords
Lipid‐lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real‐world observational analysis of a health claims database
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.1111/dom.13372
Abstract: Fenofibrate and statins reduced the need for diabetic retinopathy (DR)‐related treatment in clinical trials. We aimed to determine whether use of lipid‐lowering medication reduces the risk of DR and the need for treatment in patients… read more here.
Keywords: diabetic retinopathy; treatment; treatment patients; need treatment ... See more keywords
A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial
Sign Up to like & getrecommendations! Published in 2024 at "Trials"
DOI: 10.1186/s13063-024-08249-9
Abstract: Background Older patients with type 2 diabetes mellitus (T2D) have an increased risk of hypoglycaemic episodes when using sulphonylureas or insulin. In the Netherlands, guidelines exist for reducing glucose-lowering medication in older patients. However, evidence… read more here.
Keywords: lowering medication; medication; glucose lowering; older patients ... See more keywords
Prophylaxis with intraocular pressure lowering medication and glaucomatous progression in patients receiving intravitreal anti-VEGF therapy.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of ophthalmology"
DOI: 10.18240/ijo.2022.10.08
Abstract: AIM To investigate whether pretreatment with pressure-lowering medication prior to anti-vascular endothelial factor (VEGF) injections had an effect on glaucomatous progression in patients with preexisting glaucoma or ocular hypertension (OHT). METHODS A total of 66… read more here.
Keywords: pressure lowering; glaucomatous progression; progression patients; lowering medication ... See more keywords
Association of Lipid Profile and Body Mass Index with Periodontal Status in Patients with Dyslipidemia with and without Lipid-lowering Medication: A Cross-sectional Study.
Sign Up to like & getrecommendations! Published in 2021 at "Oral health & preventive dentistry"
DOI: 10.3290/j.ohpd.b966783
Abstract: PURPOSE To investigate the relationship between periodontal parameters and lipid profiles. SUBJECTS AND METHODS A total of 48 subjects with dyslipidemia, consisting of 33 subjects who did not receive lipid-lowering medication (NLM) and 15 subjects… read more here.
Keywords: index; periodontal status; lowering medication; lipid lowering ... See more keywords